Tuesday, April 30, 2019

Glenmark launches cheaper SGLT2 inhibitor class of anti-diabetes drug in India

Glenmark launches cheaper SGLT2 inhibitor class of anti-diabetes drug in India The drug, generically called as Remogliflozin etabonate, is used in the treatment of type-2 diabetes mellitus in adults.

from Moneycontrol Business News http://bit.ly/2WilzOg

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...